Showing Publication (BOOCOCK 2007_01)
Boocock D.J., Faust G.E., Patel K.R., Schinas A.M., Brown V.A., Ducharme M.P., Booth T.D., Crowell J.A., Perloff M., Gescher A.J., Steward W.P., Brenner D.E. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16:1246-52 PubMed (17548692)
Abbreviation: BOOCOCK 2007_01
Pubmed ID: 17548692
Metabolism
This publication was used in 4 intervention studies.
Source | Metabolite | Biofluid | Organism | |
---|---|---|---|---|
Resveratrol | Resveratrol | plasma | human | Pharmacokinetics |
Resveratrol | Resveratrol 3-sulfate | plasma | human | Pharmacokinetics |
Resveratrol | Resveratrol | urine | human | Pharmacokinetics |
Resveratrol | Resveratrol 3-sulfate | urine | human | Pharmacokinetics |
Resveratrol | Resveratrol | plasma | human | Pharmacokinetics |
Resveratrol | Resveratrol 3-sulfate | plasma | human | Pharmacokinetics |
Resveratrol | Resveratrol | urine | human | Pharmacokinetics |
Resveratrol | Resveratrol 3-sulfate | urine | human | Pharmacokinetics |
Resveratrol | Resveratrol | plasma | human | Pharmacokinetics |
Resveratrol | Resveratrol 3-sulfate | plasma | human | Pharmacokinetics |
Resveratrol | Resveratrol | urine | human | Pharmacokinetics |
Resveratrol | Resveratrol 3-sulfate | urine | human | Pharmacokinetics |
Resveratrol | Resveratrol | plasma | human | Pharmacokinetics |
Resveratrol | Resveratrol 3-sulfate | plasma | human | Pharmacokinetics |
Resveratrol | Resveratrol | urine | human | Pharmacokinetics |
Resveratrol | Resveratrol 3-sulfate | urine | human | Pharmacokinetics |